References on slide:
1.Vermunt L, Sikkes SAM, van den Hout A, et al; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. Duration of preclinical, prodromal, and dementia stages of Alzheimer’s disease in relation to age, sex, and APOE genotype. Alzheimers Dement 2019; 15 (7): 888–898.
2.Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med 2011; 3 (111): 111cm33.
3.Gregory S, Saunders S, Ritchie CW. Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer’s disease. Lancet Healthy Longev 2022; 3 (11): e797–e803.
4.Therriault J, Zimmer ER, Benedet AL, et al. Staging of Alzheimer’s disease: past, present, and future perspectives. Trends Mol Med 2022; 28 (9): 726–741.
5.Hampel H, Lista S, Vergallo A; Neurodegeneration Precision Medicine Initiative. In Gauthier S, Webster C, Servaes S, et al. World Alzheimer Report 2022. Life after diagnosis: navigating treatment, care and support. London, England: Alzheimer’s Disease International.
